Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking MTOR Signaling

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Feb 6

PMID 32021279

Citations 11

Authors

Sen Lin

Hongbo Wang

Wenjuan Yang

Aiguang Wang

Chao Geng

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to evaluate the specific role of colon cancer-associated transcript 2 (CCAT2) on gastric cancer (GC), and reveal the potential regulatory mechanism relating to mammalian target of rapamycin (mTOR) signaling.

Methods: The expression of CCAT2 was detected in GC tissues and cells by quantitative real-time PCR (qRT-PCR), and its relation with the pathologic characteristics of GC patients was analyzed. HGC-27 and SGC-7901 cells were transfected with siRNA-CCAT2 to silence CCAT2, and HGC-27 cells were then treated with an mTOR agonist Leucine (Leu) to activate mTOR signaling. The cell proliferation was evaluated by cell viability and colony formation. The cell cycle and apoptosis, and the migration and invasion abilities were detected by Flow cytometry, and Transwell assay, respectively. The expression of PCNA (proliferation marker), Snail, N-cadherin, E-cadherin (invasion markers), P53, Caspase-8, Bcl-2 (apoptosis markers), LC3-II/LC3-I, ATG3, p62 (autophagy makers), phosphorylated mTOR (p-mTOR), p-AKT, and p-p70S6K (mTOR signaling markers) were detected by Western blot.

Results: CCAT2 was upregulated in GC tissues and cells, and positively associated with the maximum tumor diameter, lymphatic metastasis, TNM staging, and low overall survival rate (P < 0.05). siRNA-CCAT2 transfection significantly inhibited the viability, colony formation, and migration and invasion abilities, blocked the cell cycle in G0/G1 phase, and promoted the apoptosis and autophagy of SGC-7901 and HGC-27 cells (P < 0.05). In addition, siRNA-CCAT2 transfection significantly upregulated P53, Caspase-8, LC3-II/LC3-I and ATG3, and downregulated PCNA, Bcl-2, p62, p-mTOR, p-AKT and p-p70S6K in SGC-7901 and HGC-27 cells (P < 0.05). siRNA-CCAT2 reversed the tumor-promoting effect of mTOR signaling activation on HGC-27 cells (P < 0.05).

Conclusion: Silencing of CCAT2 inhibited the proliferation, migration and invasion, and promoted the apoptosis and autophagy of GC cells through blocking mTOR signaling.

Citing Articles

LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing.

Deng H, Gao J, Cao B, Qiu Z, Li T, Zhao R Cell Oncol (Dordr). 2023; 46(6):1675-1690.

PMID: 37354353 DOI: 10.1007/s13402-023-00835-4.

Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma.

Riquelme I, Perez-Moreno P, Mora-Lagos B, Ili C, Brebi P, Roa J Int J Mol Sci. 2023; 24(7).

PMID: 37047267 PMC: 10094576. DOI: 10.3390/ijms24076294.

Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers.

Ma S, Wang W, Zhang D, Zhao G, Lu Z Chin Med J (Engl). 2022; 135(23):2785-2797.

PMID: 36103972 PMC: 9945556. DOI: 10.1097/CM9.0000000000002286.

Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance.

Xu G, Chen H, Wu S, Chen J, Zhang S, Shao G Cell Death Dis. 2022; 13(8):683.

PMID: 35931669 PMC: 9356061. DOI: 10.1038/s41419-022-05033-y.

Gemini Curcumin Suppresses Gastric Cancer AGS Cell Proliferation Through Modulation of and Genes.

Jabbari N, Hafez Ghoran S, Semsari H, Hussen B, Babaei E Turk J Pharm Sci. 2022; 19(3):239-245.

PMID: 35773976 PMC: 9254092. DOI: 10.4274/tjps.galenos.2021.03502.

References

Yu Z, Wang Z, Lee K, Yuan P, Ding J . Effect of silencing colon cancer-associated transcript 2 on the proliferation, apoptosis and autophagy of gastric cancer BGC-823 cells. Oncol Lett. 2018; 15(3):3127-3132. PMC: 5778869. DOI: 10.3892/ol.2017.7677. View

Xie P, Cao H, Li Y, Wang J, Cui Z . Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b. Cancer Biomark. 2017; 21(1):123-133. DOI: 10.3233/CBM-170388. View

Al-Batran S, Ducreux M, Ohtsu A . mTOR as a therapeutic target in patients with gastric cancer. Int J Cancer. 2011; 130(3):491-6. DOI: 10.1002/ijc.26396. View

Wang C, Hua L, Yao K, Chen J, Zhang J, Hu J . Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015; 8(1):779-85. PMC: 4348805. View

Schlafli A, Adams O, Galvan J, Gugger M, Savic S, Bubendorf L . Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer. Oncotarget. 2016; 7(26):39544-39555. PMC: 5129952. DOI: 10.18632/oncotarget.9647. View

Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang J . β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer. 2011; 11:183. PMC: 3115914. DOI: 10.1186/1471-2407-11-183. View

Ichimura Y, Komatsu M . Selective degradation of p62 by autophagy. Semin Immunopathol. 2010; 32(4):431-6. DOI: 10.1007/s00281-010-0220-1. View

Wu Z, Li Y, Wu Y, Wang Y, Nian W, Wang L . Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway. Eur Rev Med Pharmacol Sci. 2017; 21(4):706-714. View

Yamashita K, Sakuramoto S, Nemoto M, Shibata T, Mieno H, Katada N . Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol. 2011; 17(29):3390-7. PMC: 3160565. DOI: 10.3748/wjg.v17.i29.3390. View

10.

Gozuacik D, Akkoc Y, Ozturk D, Kocak M . Autophagy-Regulating microRNAs and Cancer. Front Oncol. 2017; 7:65. PMC: 5394422. DOI: 10.3389/fonc.2017.00065. View

11.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

12.

Ruan R, Zhao X . LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma. Eur Rev Med Pharmacol Sci. 2018; 22(10):2978-2984. DOI: 10.26355/eurrev_201805_15053. View

13.

Hewitt G, Carroll B, Sarallah R, Correia-Melo C, Ogrodnik M, Nelson G . SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair. Autophagy. 2016; 12(10):1917-1930. PMC: 5391493. DOI: 10.1080/15548627.2016.1210368. View

14.

Xin Y, Li Z, Zheng H, Chan M, Wu W . CCAT2: A novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017; 50(3). PMC: 6529071. DOI: 10.1111/cpr.12342. View

15.

Wu S, Hao Y, Qiu J, Zhang D, Yu C, Li W . High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion. Minerva Med. 2017; 108(4):317-323. DOI: 10.23736/S0026-4806.17.04703-6. View

16.

Yi J, Jang J, Cho J, Do I, Hong M, Kim S . MerTK is a novel therapeutic target in gastric cancer. Oncotarget. 2017; 8(57):96656-96667. PMC: 5722512. DOI: 10.18632/oncotarget.3750. View

17.

Li Z, Shen J, Chan M, Wu W . TUG1: a pivotal oncogenic long non-coding RNA of human cancers. Cell Prolif. 2016; 49(4):471-5. PMC: 6496395. DOI: 10.1111/cpr.12269. View

18.

Schuler M, Green D . Mechanisms of p53-dependent apoptosis. Biochem Soc Trans. 2001; 29(Pt 6):684-8. DOI: 10.1042/0300-5127:0290684. View

19.

Murayama T, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J . Relation between outcomes and localisation of p-mTOR expression in gastric cancer. Br J Cancer. 2009; 100(5):782-8. PMC: 2653759. DOI: 10.1038/sj.bjc.6604915. View

20.

Wang Y, Liu J, Lv P, Dang Y, Gao J, Wang Y . Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2. Am J Cancer Res. 2016; 6(11):2651-2660. PMC: 5126280. View